Fibromyalgia Management – FDA Approves Cymbalta Drug

by General Manager on 23rd June 2008

in All ME/ Chronic Fatigue Syndrome And Fibromyalgia News

FDA Approves Cymbalta(R) for the Management of Fibromyalgia
FOXBusiness
Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. ..

Other interesting news:

Phase II Trial of Droxidopa in Fibromyalgia is Granted MHRA Approval
Forest and Cypress Announce Submission of New Drug Application for ... - FOX News
Hemispherx Biopharma's CFC Drug Reviewed In UK - Update - Trading Markets (press release)
Group Exercise, Education, and Combination Self-management in ... - Archives of Internal Medicine
ACR: Duloxetine Falls Short in Phase III Fibromyalgia Trial - MedPage Today

Leave a Comment

Previous post: Chronic Fatigue Syndrome victim claims God performed a miracle healing

Next post: Norwich ME Sufferer Wins Court Ruling…

Free E-Magazine

To subscribe to the completely FREE, popular, Sleepydust Emagazine or to learn more about it click here...
Free ME/CFS Video

For the friends and family of ME/CFS sufferers. Click here...
Reviews – What Helps?

To read helpful reviews of supplements & items for M.E. / Chronic Fatigue Syndrome & Fibromyalgia, click here...
Share Your Experiences…

There's nothing like reading first-hand experience of other sufferers, who have 'been there'. What's your story?

And would you be willing to share it?

Share your experiences of ME/ Chronic Fatigue Syndrome and/or Fibromyalgia here…

Fibromyalgia Management – FDA Approves Cymbalta Drug

Other interesting news:

Free E-Magazine

Free ME/CFS Video

Reviews – What Helps?

Share Your Experiences…

Search:

Latest News

Hot Topics